Fully automated solution for SARS-CoV-2 NGS-based testing data analysis

Our world is dealing with a global pandemic that threatens life as we know it. The rapidly spreading coronavirus SARS-CoV-2 is a major public health emergency. Worldwide, scientists and healthcare providers are working together to provide information and solutions to fight this disease. As part of this healthcare community, Flomics is actively monitoring and contributing to the latest research findings, especially in the Next Generation Sequencing (NGS) field.

Flomics has joined forces with international biotech partners, specialized in NGS tests, to develop a cloud-based solution for COVID19 detection and research. Whether you work in a hospital, clinic or research laboratory, with a few clicks you can transform your raw data into interpretable clinical information that will help manage this pandemic, without the need for bioinformatics expertise.

Flomics team offers end-to-end support from experimental setup selection to customized data reporting.

Automated COVID-19 next generation sequencing data analysis

Access to FlomicsCOVID19

Our pipeline will automatically take your data through the following steps:

Quality control

Adapter trimming

Primer removal (for amplicon data)

Viral load calculation

Read alignment

Variant calling and annotation

Strain identification

Intuitive reporting

Flexible

A pipeline adapted to your needs:

Metagenomic, Amplicon-seq

Compatible with all sequencing platforms: Illumina, MGI, …

Always up-to-date with the latest SARS-CoV-2 genome databases

Ready for data from:

Any targeted SARS-CoV-2 Amplicon sequencing kit

Your usual Total RNA kit for shotgun metagenomics

Get in touch and we can assist you in the optimal experimental setup